Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

Among liquid biopsy–based methodologies, cell-free DNA (cfDNA)–related early diagnosis technology is relatively mature, and relevant commercial detection kits have been approved. 8 The main ...

Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer The following represents disclosure information provided by authors of this manuscript.

In a pregnant person, some of this cell-free DNA is fetal DNA from the placenta. In the epiphany that spawned NIPT, Hong Kong–based researcher Dennis Lo realized that even though fetal DNA is ...

iPhone Fold — Apple is reportedly partnering with Samsung for a 'crease-free' display iPhone Fold just tipped for breakthrough display technology — and it could change everything ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation.

Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

Myriad Genetics' research allows prenatal cell-free DNA screening as early as eight weeks gestation, a significant advancement in prenatal genetic testing.

Post this Alchemy cell-free DNA technology is now available at research grade, providing researchers with a faster, more efficient method to produce high-quality DNA templates.

Recently, cell-free DNA (cfDNA) fragmentomic features, which encompass fragment size, end motifs, breakpoint motifs, and nucleosome footprints, have demonstrated the potential of cfDNA fragmentomics ...